218 related articles for article (PubMed ID: 19008288)
21. SPECT/CT imaging using a spiral CT scanner for anatomical localization: Impact on diagnostic accuracy and reporter confidence in clinical practice.
Roach PJ; Schembri GP; Ho Shon IA; Bailey EA; Bailey DL
Nucl Med Commun; 2006 Dec; 27(12):977-87. PubMed ID: 17088684
[TBL] [Abstract][Full Text] [Related]
22. Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma.
Fujita A; Hyodoh H; Kawamura Y; Kanegae K; Furuse M; Kanazawa K
Clin Nucl Med; 2000 Jun; 25(6):440-2. PubMed ID: 10836692
[TBL] [Abstract][Full Text] [Related]
23. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
Sodee DB; Sodee AE; Bakale G
Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
[TBL] [Abstract][Full Text] [Related]
24. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
Giovanella L; Squin N; Ghelfo A; Ceriani L
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
[TBL] [Abstract][Full Text] [Related]
25. Multimodality imaging of malignant pheochromocytoma.
Esfandiari NH; Shulkin BL; Bui C; Jaffe CA
Clin Nucl Med; 2006 Dec; 31(12):822-5. PubMed ID: 17117086
[TBL] [Abstract][Full Text] [Related]
26. Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma.
Lam MG; Lips CJ; Jager PL; Dullaart RP; Lentjes EG; van Rijk PP; de Klerk JM
J Clin Endocrinol Metab; 2005 Oct; 90(10):5888-95. PubMed ID: 16046591
[TBL] [Abstract][Full Text] [Related]
27. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.
Loh KC; Fitzgerald PA; Matthay KK; Yeo PP; Price DC
J Endocrinol Invest; 1997 Dec; 20(11):648-58. PubMed ID: 9492103
[TBL] [Abstract][Full Text] [Related]
28. False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.
Takasu N; Hayashi M; Takara M; Iha T; Kouki T; Ohshiro Y; Ogawa Y
Intern Med; 2007; 46(20):1717-21. PubMed ID: 17938527
[TBL] [Abstract][Full Text] [Related]
29. Metastases of predominantly dopamine-secreting phaeochromocytoma that did not accumulate meta-iodobenzylguanidine: imaging with whole body positron emission tomography using 18F-labelled deoxyglucose.
Taniguchi K; Ishizu K; Torizuka T; Hasegawa S; Okawada T; Ozawa T; Iino K; Taniguchi M; Ikematsu Y; Nishiwaki Y; Kida H; Waki S; Uchimura M
Eur J Surg; 2001 Nov; 167(11):866-70. PubMed ID: 11848244
[No Abstract] [Full Text] [Related]
30. Aspects on radionuclide therapy in malignant pheochromocytomas.
Forssell-Aronsson E; Bernhardt P; Wängberg B; Kölby L; Nilsson O; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():498-504. PubMed ID: 17102117
[TBL] [Abstract][Full Text] [Related]
31. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Hadi M; Chen CC; Whatley M; Pacak K; Carrasquillo JA
J Nucl Med; 2007 Jul; 48(7):1077-83. PubMed ID: 17574980
[TBL] [Abstract][Full Text] [Related]
32. [Pheochromocytoma in internal medicine: distinctive features and place of 123I MIBG scintigraphy].
Noblet-Dick M; Grunenberger F; Brunot B; Jaeck D; Schlienger JL
Rev Med Interne; 2003 Jun; 24(6):358-65. PubMed ID: 12814824
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG.
Tang HR; Da Silva AJ; Matthay KK; Price DC; Huberty JP; Hawkins RA; Hasegawa BH
J Nucl Med; 2001 Feb; 42(2):237-47. PubMed ID: 11216522
[TBL] [Abstract][Full Text] [Related]
34. Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach.
Andersen KF; Altaf R; Krarup-Hansen A; Kromann-Andersen B; Horn T; Christensen NJ; Hendel HW
Cancer Treat Rev; 2011 Apr; 37(2):111-9. PubMed ID: 20675056
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study.
Lumachi F; Tregnaghi A; Zucchetta P; Cristina Marzola M; Cecchin D; Grassetto G; Bui F
Nucl Med Commun; 2006 Jul; 27(7):583-7. PubMed ID: 16794519
[TBL] [Abstract][Full Text] [Related]
36. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG?: Comparison with planar scintigraphy and SPECT in pheochromocytoma.
Sharma P; Dhull VS; Jeph S; Reddy RM; Singh H; Naswa N; Bal C; Kumar R
Clin Nucl Med; 2013 Sep; 38(9):e346-53. PubMed ID: 23510889
[TBL] [Abstract][Full Text] [Related]
37. MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
Sharp SE; Trout AT; Weiss BD; Gelfand MJ
Radiographics; 2016; 36(1):258-78. PubMed ID: 26761540
[TBL] [Abstract][Full Text] [Related]
38. [Pheocromocytoma with negative MIBG].
Bento A; Vasconcelos J; Jara A
Rev Port Cardiol; 2010 Jun; 29(6):1059-64. PubMed ID: 20967963
[TBL] [Abstract][Full Text] [Related]
39. Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?
Kölby L; Bernhardt P; Johanson V; Wängberg B; Muth A; Jansson S; Forssell-Aronsson E; Nilsson O; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():491-7. PubMed ID: 17102116
[TBL] [Abstract][Full Text] [Related]
40. Improved quality of pediatric 123I-MIBG images with medium-energy collimators.
Snay ER; Treves ST; Fahey FH
J Nucl Med Technol; 2011 Jun; 39(2):100-4. PubMed ID: 21565952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
